BACKGROUND: The incidence of penile cancer in Indian men is high. Little is known about genital human papillomavirus (HPV) infection in Indian HIV-seropositive men who have sex with men (MSM), a population that may be at particularly high risk for genital HPV infection and, potentially, penile cancer. In this study, we assessed the prevalence and risk factors for genital HPV infection in this population. DESIGN AND METHODS: Three hundred HIV-seropositive MSM were recruited from 2 clinical sites in India. They were tested for genital HPV infection using L1 HPV DNA polymerase chain reaction with probes specific for 29 types and a mixture of 10 additional types. Participants received an interviewer-administered questionnaire that included questions on demographics and behaviors. RESULTS: Human papillomavirus data were available from 299 participants. The prevalence of any HPV type in the penis and scrotum was 55% and 54%, respectively. Human papillomavirus type 35 was the most common oncogenic HPV type followed by HPV-16. In multivariate analysis, being the insertive partner with 100+ male partners increased the odds of any penile HPV infection compared with not being insertive with any partners (odds ratio, 2.5; 95% confidence interval, 1.3-5.1). Circumcision was protective against penile HPV infection (odds ratio, 0.39; 95% confidence interval, 0.19-0.76). CONCLUSIONS: The prevalence of penile and scrotal HPV infection was high among Indian HIV-seropositive MSM. The most common oncogenic HPV type in this population, HPV-35, is not included in any currently available HPV vaccines. Insertive anal sex with men and lack of circumcision were the primary risk factors for penile HPV infection in this population.
BACKGROUND: The incidence of penile cancer in Indian men is high. Little is known about genital human papillomavirus (HPV) infection in Indian HIV-seropositivemen who have sex with men (MSM), a population that may be at particularly high risk for genital HPV infection and, potentially, penile cancer. In this study, we assessed the prevalence and risk factors for genital HPV infection in this population. DESIGN AND METHODS: Three hundred HIV-seropositive MSM were recruited from 2 clinical sites in India. They were tested for genital HPV infection using L1 HPV DNA polymerase chain reaction with probes specific for 29 types and a mixture of 10 additional types. Participants received an interviewer-administered questionnaire that included questions on demographics and behaviors. RESULTS:Human papillomavirus data were available from 299 participants. The prevalence of any HPV type in the penis and scrotum was 55% and 54%, respectively. Human papillomavirus type 35 was the most common oncogenic HPV type followed by HPV-16. In multivariate analysis, being the insertive partner with 100+ male partners increased the odds of any penile HPV infection compared with not being insertive with any partners (odds ratio, 2.5; 95% confidence interval, 1.3-5.1). Circumcision was protective against penile HPV infection (odds ratio, 0.39; 95% confidence interval, 0.19-0.76). CONCLUSIONS: The prevalence of penile and scrotal HPV infection was high among Indian HIV-seropositive MSM. The most common oncogenic HPV type in this population, HPV-35, is not included in any currently available HPV vaccines. Insertive anal sex with men and lack of circumcision were the primary risk factors for penile HPV infection in this population.
Authors: Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano Journal: J Infect Dis Date: 2006-09-12 Impact factor: 5.226
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Aruna Alahari Dhir; Sheela Sawant; Rajesh P Dikshit; Purvish Parikh; Shyam Srivastava; Rajan Badwe; Sunil Rajadhyaksha; K A Dinshaw Journal: Cancer Causes Control Date: 2007-11-09 Impact factor: 2.506
Authors: Joel M Palefsky; Elizabeth A Holly; Jimmy T Efirdc; Maria Da Costa; Naomi Jay; J Michael Berry; Teresa M Darragh Journal: AIDS Date: 2005-09-02 Impact factor: 4.177
Authors: Aaron A R Tobian; David Serwadda; Thomas C Quinn; Godfrey Kigozi; Patti E Gravitt; Oliver Laeyendecker; Blake Charvat; Victor Ssempijja; Melissa Riedesel; Amy E Oliver; Rebecca G Nowak; Lawrence H Moulton; Michael Z Chen; Steven J Reynolds; Maria J Wawer; Ronald H Gray Journal: N Engl J Med Date: 2009-03-26 Impact factor: 91.245
Authors: Steven A Safren; Bella Devaleenal; Katie B Biello; Shruta Rawat; Beena E Thomas; Kristen S Regenauer; Vinoth Balu; C Andres Bedoya; Alpana Dange; Sunil Menon; Conall O'Cleirigh; Dicky Baruah; Vivek Anand; Luke E Hanna; Ramesh Karunaianantham; Rakesh Thorat; Soumya Swaminathan; Matthew J Mimiaga; Kenneth H Mayer Journal: Int J STD AIDS Date: 2020-12-15 Impact factor: 1.456
Authors: Jessica A Kahn; Marvin Belzer; Xiaofei Chi; Jeannette Lee; Aditya H Gaur; Kenneth Mayer; Jaime Martinez; Donna C Futterman; Elizabeth A Stier; Mary E Paul; Elizabeth Y Chiao; Daniel Reirden; Steven E Goldstone; Ana P Ortiz Martinez; Edward R Cachay; Luis F Barroso; Maria Da Costa; Craig M Wilson; Joel M Palefsky Journal: Papillomavirus Res Date: 2019-01-15
Authors: Gad Murenzi; Hae-Young Kim; Athanase Munyaneza; Patrick Tuyisenge; Thierry M Zawadi; Alex M Buteera; Adebola Adedimeji; Leon Mutesa; Philip E Castle; Kathryn Anastos; Joel M Palefsky Journal: J Acquir Immune Defic Syndr Date: 2020-08-15 Impact factor: 3.771